HK1016169A1 - Hydrolysis-promoting taxane hydrophobic derivatives - Google Patents

Hydrolysis-promoting taxane hydrophobic derivatives

Info

Publication number
HK1016169A1
HK1016169A1 HK99101119A HK99101119A HK1016169A1 HK 1016169 A1 HK1016169 A1 HK 1016169A1 HK 99101119 A HK99101119 A HK 99101119A HK 99101119 A HK99101119 A HK 99101119A HK 1016169 A1 HK1016169 A1 HK 1016169A1
Authority
HK
Hong Kong
Prior art keywords
taxane
hydrolysis
promoting
hydrocarbon
hydrophobic derivatives
Prior art date
Application number
HK99101119A
Other languages
English (en)
Inventor
Eric Mayhew
Shaukat Ali
Andrew S Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of HK1016169A1 publication Critical patent/HK1016169A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
HK99101119A 1995-09-12 1999-03-18 Hydrolysis-promoting taxane hydrophobic derivatives HK1016169A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US357595P 1995-09-12 1995-09-12
PCT/US1996/014631 WO1997010234A1 (en) 1995-09-12 1996-09-12 Hydrolysis-promoting taxane hydrophobic derivatives

Publications (1)

Publication Number Publication Date
HK1016169A1 true HK1016169A1 (en) 1999-10-29

Family

ID=21706522

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101119A HK1016169A1 (en) 1995-09-12 1999-03-18 Hydrolysis-promoting taxane hydrophobic derivatives

Country Status (22)

Country Link
US (1) US5703117A (cs)
EP (1) EP0902783B1 (cs)
JP (1) JP4192208B2 (cs)
KR (1) KR100401220B1 (cs)
CN (1) CN1100770C (cs)
AT (2) ATE309235T1 (cs)
CA (1) CA2231750C (cs)
CZ (1) CZ288562B6 (cs)
DE (2) DE69620802T2 (cs)
DK (2) DK0902783T3 (cs)
ES (2) ES2179208T3 (cs)
HK (1) HK1016169A1 (cs)
HU (1) HU226325B1 (cs)
IL (1) IL123595A (cs)
MX (1) MX9801871A (cs)
NO (1) NO319521B1 (cs)
NZ (1) NZ318300A (cs)
PL (1) PL187738B1 (cs)
PT (1) PT902783E (cs)
SK (1) SK283199B6 (cs)
TR (1) TR199800443T1 (cs)
WO (1) WO1997010234A1 (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) * 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
PT1964557E (pt) 1997-11-10 2013-02-20 Sloan Kettering Inst Cancer Processo para a produção de formulações de trióxido de arsénio
BR9911031A (pt) * 1998-05-20 2002-01-29 Liposome Co Inc Novas formulações em partìculas
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
DE60004630T2 (de) * 1999-01-12 2004-06-17 Quanam Medical Corp., Santa Clara Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) * 2000-08-29 2003-08-19 Micron Technology, Inc. Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (en) * 2001-10-22 2008-12-31 Viroblock SA New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
EP1461056A4 (en) * 2001-11-26 2006-01-25 Supergen Inc PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLATED CICRIC OIL IN PHARMACEUTICAL COMPOSITIONS
AU2003249882B2 (en) * 2002-06-26 2008-09-18 Medigene Ag Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
WO2004069224A2 (en) 2003-02-03 2004-08-19 Neopharm, Inc. Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
JP5139814B2 (ja) * 2005-02-18 2013-02-06 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー 医療装置に結合した改善された疎水性を有した薬剤
WO2006110862A2 (en) * 2005-04-12 2006-10-19 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
JP2011517683A (ja) * 2008-04-10 2011-06-16 アブラクシス バイオサイエンス， エルエルシー 疎水性タキサン誘導体の組成物およびその使用
AU2009234127B2 (en) * 2008-04-10 2015-04-30 Abraxis Bioscience, Llc Compositions of hydrophobic taxane derivatives and uses thereof
WO2011038278A2 (en) 2009-09-25 2011-03-31 Wisconsin Alumni Research Foundation Micelle encapsulation of therapeutic agents
CN105503844A (zh) * 2015-12-11 2016-04-20 上海大学 C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
EP0626953A4 (en) * 1992-12-23 1995-05-03 Bristol Myers Squibb Co NEW SIDE CHAINS WEARING TAXANS AND THEIR INTERMEDIATE PRODUCTS.
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives

Also Published As

Publication number Publication date
MX9801871A (es) 1998-05-31
ATE309235T1 (de) 2005-11-15
ES2252347T3 (es) 2006-05-16
AU706290B2 (en) 1999-06-10
WO1997010234A1 (en) 1997-03-20
ES2179208T3 (es) 2003-01-16
DE69635428T2 (de) 2006-06-14
PT902783E (pt) 2002-09-30
DE69620802T2 (de) 2002-10-10
PL325477A1 (en) 1998-07-20
TR199800443T1 (xx) 1998-06-22
PL187738B1 (pl) 2004-09-30
DK0902783T3 (da) 2002-07-22
HU226325B1 (en) 2008-08-28
NO981071D0 (no) 1998-03-11
CZ288562B6 (cs) 2001-07-11
CZ71198A3 (cs) 1998-07-15
EP0902783A4 (cs) 1999-03-24
NO319521B1 (no) 2005-08-22
CN1100770C (zh) 2003-02-05
SK33498A3 (en) 1998-08-05
CA2231750A1 (en) 1997-03-20
EP0902783B1 (en) 2002-04-17
DE69620802D1 (de) 2002-05-23
US5703117A (en) 1997-12-30
CA2231750C (en) 2006-07-11
IL123595A (en) 2000-10-31
HUP9901433A2 (hu) 2001-04-28
EP0902783A1 (en) 1999-03-24
JP4192208B2 (ja) 2008-12-10
SK283199B6 (sk) 2003-03-04
KR100401220B1 (ko) 2004-03-20
NZ318300A (en) 1999-08-30
HUP9901433A3 (en) 2001-05-28
KR19990044409A (ko) 1999-06-25
IL123595A0 (en) 1998-10-30
AU6975696A (en) 1997-04-01
ATE216377T1 (de) 2002-05-15
DK1229030T3 (da) 2006-02-13
JP2001519755A (ja) 2001-10-23
DE69635428D1 (de) 2005-12-15
NO981071L (no) 1998-05-12
CN1202166A (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
IL123595A0 (en) Hydrolysis-promoting taxane hydrophobic derivatives
IL133585A0 (en) Soluble prodrugs of paclitaxel
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
AU6331898A (en) Forskohlin for promoting lean body mass
PT802911E (pt) Derivados de taxano hidrofobos
AU1406895A (en) Inhalable contrast agent
EP0693924A4 (en) METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS
DK0975595T3 (da) Kokainanaloger
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283D0 (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
EP1229030A3 (en) Hydrolysis-promoting taxane hydrophobic derivates
JPS6485930A (en) Anticancer composition and therapy using monoclonal antibody and il-2 against gd3 ganglioside
NZ307601A (en) Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
ES8605989A1 (es) Un metodo de preparar un complejo de fibronectina, dextrano y farmaco
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
NZ335189A (en) Use of taxane hydrophobic derivatives for the treatment of cancer
IT208536Z2 (it) Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.
UA41462C2 (uk) Спосіб лікування гострого пієлонефриту

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080911